Vor Biopharma

Vor Biopharma

MA - Cambridge
Pharmaceutical3 H-1B visas (FY2023)

Focus: CAR-T Stem Cell Therapy

Vor Biopharma is a life sciences company focused on CAR-T Stem Cell Therapy.

Cell TherapyGene Therapy
Open Jobs
13

Pipeline & Clinical Trials

Clinical Trials (1)
NCT05309733A Long-term Follow-up Study of Patients Who Received VOR33
N/A
Clinical Trials (1)
NCT04849910Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS
Phase 1/2
Clinical Trials (1)
NCT05984199Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant
Phase 1/2
Clinical Trials (1)
NCT06456580A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Phase 3
Phase 3
Clinical Trials (1)
NCT05306574A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)
Phase 3
Phase 3
Clinical Trials (1)
NCT06456567A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)
Phase 3
Phase 3
Clinical Trials (1)
NCT07404865Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Phase 3

Open Jobs (13)

Interview Prep Quick Facts
Portfolio: 7 clinical trials
Top TAs: Oncology, Immunology, Neurology
H-1B (2023): 3 approvals
Open Roles: 13 active jobs
Therapeutic Area Focus
Oncology
3 pipeline
Immunology
2 pipeline
Neurology
1 pipeline
Marketed
Pipeline

Hiring Trend

Stable
13
Open Roles
+1
Added
-1
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
3
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub